Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec;6(Suppl 3):S175-S181.
doi: 10.4103/2231-0762.197183.

Role of odanacatib in reducing bone loss due to endodontic disease: An overview

Rachana Bahuguna  1 , Atul Jain  2 , Suleman Abbas Khan  1 , M S Arvind  2
Affiliations
Review

Role of odanacatib in reducing bone loss due to endodontic disease: An overview

Rachana Bahuguna et al. J Int Soc Prev Community Dent. 2016 Dec.

Abstract

Aims and objectives: Through a comprehensive literature review, this article provides an overview of the potential role of odanacatib (ODN) in reducing bone loss due to endodontic disease.

Materials and methods: A literature review was performed in PubMed Central, MEDLINE, Cochrane Library, and EBSCO databases. The articles identified included those published between 2002 and 2016. Based on the predetermined inclusion and exclusion criteria, out of 237 articles found, 50 were selected for this review.

Results: Cathepsin K (CstK), which is indispensible to the immune system, also plays an important role in osteoclastic bone resorption. ODN, which is an orally active, selective, and effective inhibitor of CstK, decreases bone resorption by selectively inhibiting proteolysis of matrix proteins by CstK, without affecting other osteoclastic activity or osteoblast viability.

Conclusion: The goal of endodontic treatment is to achieve a clinically asymptomatic state along with formation of reparative bone. This process could take 6 months or longer, hence, an earlier reversal of the resorption process could lead to faster healing and resolution of the periapical lesion. Use of ODN can be of help in achieving this goal.

Keywords: Cathepsin K (Ctsk); cytokines; innate immunity; odanacatib (ODN); toll-like receptor (TLRs).

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Kassem A, Lindholm C, Lerner UH. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. PLoS One. 2016;11:e0156708. - PMC - PubMed
    1. Chen Q, Hou T, Luo F, Wu X, Xie Z, Xu J. Involvement of toll-like receptor 2 and pro-apoptotic signaling pathways in bone remodeling in osteomyelitis. Cell Physiol Biochem. 2014;34:1890–900. - PubMed
    1. Bar-Shavit Z. Taking a toll on the bones: Regulation of bone metabolism by innate immune regulators. J Autoimmun. 2008;41:195–203. - PubMed
    1. Zhao R, Wang X, Feng F. Upregulated Cellular Expression of IL-17 by CD4+ T-Cells in Osteoporotic Postmenopausal Women. Ann Nutr Metab. 2016;68:113–8. - PubMed
    1. Yang S, Zhu L, Xiao L, Shen Y, Wang L, Peng B, et al. Imbalance of interlukin-17 + T-cell and Foxp3+ regulatory T-cell dynamics in rat periapical lesions. J Endod. 2014;40:56–62. - PubMed